ArticleMethodist DeBakey cardiovascular journal2025
TAV-in-TAV Explant Through Surgical Resection of Prosthetic Valve Leaflets Under Direct Vision: SURPLUS.
Article in Methodist DeBakey cardiovascular journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Current Evidence, Emerging Evidence, and Decision-Making: An Algorithm for Leaflet Modification Procedures.JACC. Cardiovascular interventions · 2026Review
- Evolving Redo Frame-Preserving Leaflet Resection: From Transcatheter to Surgical Aortic Valves.Annals of thoracic surgery short reports · 2026Article
- Managing Transcatheter Aortic Valve Failure.Structural heart : the journal of the Heart Team · 2026Review
- Surgical Explantation of Transcatheter Aortic Valve Requires Patient-Tailored Management, but Challenges Remain.Journal of cardiovascular development and disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter aortic valve replacement (TAVR) has become a widely utilized procedure for treating aortic stenosis (AS). However, TAVR-related complications are rising, with TAVR explants becoming the fastest growing cardiac surgery procedure. We report a case of an 80-year-old female with severe AS status post TAVR and subsequent TAV-in-TAV a few years later. She was found to have severe stenosis of her more recent TAV and was scheduled for surgical TAVR explant. The inner, most recent TAV was completely removed, and only the leaflets of the outer, older TAV were resected, sparing the stent frame. This was followed by deployment of a new TAV within the preserved frame under direct visualization. The patient's postoperative recovery was uncomplicated, and 1-month follow-up was reassuring. We highlight the advantages of this approach in minimizing aortic manipulation, reducing the risk of aortic wall damage, and potentially optimizing overall outcomes in a high-risk procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.